ENDO 2025: GLP-1 Receptor Agonists as Multisystem Therapies in Type 2 Diabetes Management
July 28th 2025Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses the expanding role of GLP-1 receptor agonists in holistic type 2 diabetes care, highlighting their cardio-renal-hepatic benefits, clinical access challenges, emerging investigational therapies, and practical strategies for individualized, guideline-based prescribing.
Read More
ADA 2025: Ready-to-Use Glucagon Empowers Diabetes Patient Safety
Ready-to-use glucagon simplifies hypoglycemia rescue by providing easy-to-use options for patients and caregivers.
Read More
ADA 2025: Breaking Barriers in Glucagon Prescription
Experts discuss the low prescription rates of ready-to-use glucagon for individuals with diabetes.
Read More
Basal Insulin Therapy in Type 2 Diabetes Management: What the Pharmacist Should Know
Guidance on the use of basal insulins (BI) and insulin pens to enable pharmacists to answer questions regarding the safe and effective use of BI for the management of diabetes.
Read More